Both HIF-1α and PGC-1α plasma levels were significantly lower in benign breast tumor cohort, with a mean of HIF-1α plasma level 6.490ng/dl (95% CI 6.192-6.788), and 127.809ng/dl (95% CI 111.974-143. Here, HIF1A is linked to breast benign neoplasm.